syringe

Menactra (Sanofi) Antitrust Settlement

Menactra Antitrust Litigation Settlement - Castro, et al. v. Sanofi Pasteur Inc., No. 11-7178

Settlement Fund:            $61,500,000
Settlement Period:          March 1, 2010 – December 31, 2014
Claim Filing Deadline:    TBD


Overview

The Court overseeing the Menactra (Sanofi) Settlement has preliminarily approved a $61.5 million settlement. Class Members such as physicians, medical practices, and health systems who bought Menactra directly from Sanofi claim that they paid higher prices than they should have for quadrivalent meningococcal vaccines (“MCV4 Vaccines”). These vaccines inoculate against four strains of bacterial meningitis. The lawsuit alleged that the higher prices resulted from Sanofi engaging in anticompetitive conduct.


Eligibility

All persons or entities in the United States and its territories that purchased Menactra directly from defendant Sanofi Pasteur Inc. (“Sanofi”) or any of its divisions, subsidiaries, predecessors or affiliates, such as VaxServe, Inc., during the period from March 1, 2010 through and including December 31, 2014 (“Settlement Period”), and excluding all governmental entities, Sanofi, Sanofi’s divisions, subsidiaries, predecessors, and affiliates, Kaiser Permanente and the Kaiser Foundation (collectively “Kaiser”), and any purchases by entities buying Menactra pursuant to a publicly negotiated price (i.e., governmental purchasers).

Generally, you are included in this case as a Class Member if you:

  • Are a person or entity (such as a medical practice), in the United States and its territories; and
  • Purchased Menactra directly from Sanofi Pasteur Inc. or any of its divisions, subsidiaries, predecessors, or affiliates (such as VaxServe, Inc.) from March 1, 2010 through and including December 31, 2014.

Status

Preliminary approval of the Settlement was granted on April 24, 2017 and the final approval hearing is currently set for October 3, 2017.

Please note that at this time, there are no funds available for distribution as the Court still has to decide whether to finally approve the Settlement.  If the Court finally approves the Settlement, the Court will also approve a Claim Form and set a deadline for Class Members to submit claims.


Enroll in MCAG's Settlement Recovery Service

If you are interested in MCAG pursuing a claim to this settlement on your behalf, please contact one of our representatives at 800-355-0466 to ensure a claim is submitted on your behalf prior to the deadline, which is yet to be determined. There are no upfront fees for this service. MCAG aligns its incentives with yours and charges a percentage of any recoveries obtained on your behalf.  Services include all the data analysis necessary to determine eligibility, document preparation, claims filing, recovery and reconciliation for enrolled customers.  If no money is recovered for your organization from the Settlement(s), then MCAG will not charge or retain a fee.

Take advantage of MCAG's experience and success with negotiating maximum returns to clients even in cases where only limited information is available.

MCAG is not the Settlement/Class Administrator, and this is not the official settlement website.